High-density lipoprotein in uremic patients: metabolism, impairment, and therapy.

MLA

Khoueiry, Georges, et al. “High-Density Lipoprotein in Uremic Patients: Metabolism, Impairment, and Therapy.” International Urology and Nephrology, vol. 46, no. 1, Jan. 2014, pp. 27–39. EBSCOhost, https://doi.org/10.1007/s11255-012-0366-y.

APA

Khoueiry, G., Abdallah, M., Saiful, F., Abi Rafeh, N., Raza, M., Bhat, T., El-Sayegh, S., Kalantar-Zadeh, K., & Lafferty, J. (2014). High-density lipoprotein in uremic patients: metabolism, impairment, and therapy. International Urology and Nephrology, 46(1), 27–39. https://doi.org/10.1007/s11255-012-0366-y

Chicago

Khoueiry, Georges, Mokhtar Abdallah, Faisal Saiful, Nidal Abi Rafeh, Muhammad Raza, Tariq Bhat, Suzanne El-Sayegh, Kamyar Kalantar-Zadeh, and James Lafferty. 2014. “High-Density Lipoprotein in Uremic Patients: Metabolism, Impairment, and Therapy.” International Urology and Nephrology 46 (1): 27–39. doi:10.1007/s11255-012-0366-y.